Nucleic-acid molecular diagnostic reagents, supporting instruments and related services for clinical testing, large-scale population screening and prenatal/genetic health management. Proprietary flow-hybridization and fluorescent qPCR/biochip platforms powering assays for HPV, STIs (gonorrhea, chlamydia, ureaplasma) and genetic disorders such as thalassemia.